Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Early Progressive Disease During Nivolumab Plus Ipilimumab Therapy Predicts Poor Survival in Japanese Patients with Advanced Renal Cell Carcinoma: A Single-Center 12-Week Landmark Study
Saved in:
| Published in: | Open Access Journal of Urology |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1868552295488159744 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Open Access Journal of Urology |
| description | |
| discipline_display | Urology, Nephrology and Andrology |
| discipline_facet | Urology, Nephrology and Andrology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:57495 |
| institution | FRELIP |
| journal_source_facet | Open Access Journal of Urology |
| last_indexed | 2026-06-20T21:17:54.275Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Early Progressive Disease During Nivolumab Plus Ipilimumab Therapy Predicts Poor Survival in Japanese Patients with Advanced Renal Cell Carcinoma: A Single-Center 12-Week Landmark Study Urology, Nephrology and Andrology General Urology, Nephrology and Andrology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Urology, Nephrology and Andrology General Urology, Nephrology and Andrology |
| subject_facet | Urology, Nephrology and Andrology General Urology, Nephrology and Andrology |
| title | Early Progressive Disease During Nivolumab Plus Ipilimumab Therapy Predicts Poor Survival in Japanese Patients with Advanced Renal Cell Carcinoma: A Single-Center 12-Week Landmark Study |
| title_alt | Enfermedad progresiva temprana durante la terapia con nivolumab más ipilimumab predice mala supervivencia en pacientes japoneses con carcinoma renal avanzado: un estudio de punto de referencia de 12 semanas en un solo centro Maladie progressive précoce sous traitement par nivolumab plus ipilimumab prédit une mauvaise survie chez les patients japonais atteints de carcinome rénal avancé : une étude monocentrique avec repère à 12 semaines Doença Progressiva Precoce Durante Terapia com Nivolumabe mais Ipilimumabe Prediz Sobrevida Ruim em Pacientes Japoneses com Carcinoma de Células Renais Avançado: Um Estudo de Marco de 12 Semanas em Centro Único |
| title_auth | Early Progressive Disease During Nivolumab Plus Ipilimumab Therapy Predicts Poor Survival in Japanese Patients with Advanced Renal Cell Carcinoma: A Single-Center 12-Week Landmark Study |
| title_es_txt | Enfermedad progresiva temprana durante la terapia con nivolumab más ipilimumab predice mala supervivencia en pacientes japoneses con carcinoma renal avanzado: un estudio de punto de referencia de 12 semanas en un solo centro |
| title_fr_txt | Maladie progressive précoce sous traitement par nivolumab plus ipilimumab prédit une mauvaise survie chez les patients japonais atteints de carcinome rénal avancé : une étude monocentrique avec repère à 12 semaines |
| title_full | Early Progressive Disease During Nivolumab Plus Ipilimumab Therapy Predicts Poor Survival in Japanese Patients with Advanced Renal Cell Carcinoma: A Single-Center 12-Week Landmark Study |
| title_fullStr | Early Progressive Disease During Nivolumab Plus Ipilimumab Therapy Predicts Poor Survival in Japanese Patients with Advanced Renal Cell Carcinoma: A Single-Center 12-Week Landmark Study |
| title_full_unstemmed | Early Progressive Disease During Nivolumab Plus Ipilimumab Therapy Predicts Poor Survival in Japanese Patients with Advanced Renal Cell Carcinoma: A Single-Center 12-Week Landmark Study |
| title_pt_txt | Doença Progressiva Precoce Durante Terapia com Nivolumabe mais Ipilimumabe Prediz Sobrevida Ruim em Pacientes Japoneses com Carcinoma de Células Renais Avançado: Um Estudo de Marco de 12 Semanas em Centro Único |
| title_short | Early Progressive Disease During Nivolumab Plus Ipilimumab Therapy Predicts Poor Survival in Japanese Patients with Advanced Renal Cell Carcinoma: A Single-Center 12-Week Landmark Study |
| title_sort | early progressive disease during nivolumab plus ipilimumab therapy predicts poor survival in japanese patients with advanced renal cell carcinoma: a single-center 12-week landmark study |
| topic | Urology, Nephrology and Andrology General Urology, Nephrology and Andrology |
| url | https://www.dovepress.com/early-progressive-disease-during-nivolumab-plus-ipilimumab-therapy-pre-peer-reviewed-fulltext-article-RRU |